Trials / Completed
CompletedNCT04754529
Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer Survivors
Influence of Yoga on Cancer-Related Stress in Cancer Survivors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Roswell Park Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial develops and test a yoga intervention in improving cancer-related stress in cancer survivors. The online hatha yoga intervention of breathing and movement incorporates both restorative poses, breathing techniques, guided meditation and may reduce stress levels and improve overall quality of health in cancer survivors.
Detailed description
PRIMARY OBJECTIVE: I. To develop and test the feasibility of a standardized 12-week online hatha yoga intervention (n=30) of breathing and movement incorporating both restorative poses, breathing techniques, guided meditation. SECONDARY OBJECTIVES: I. To evaluate the yoga intervention in relation to self-reported levels of stress and quality of life in cancer survivors (n=30). II. Feasibility of collecting blood and saliva at baseline and post-intervention for stress biomarkers, including cortisol and norepinephrine. EXPLORATORY OBJECTIVE: I. To determine how behavior change, quality of life (QoL), and biomarkers of adrenergic stress, inflammation, and immunosuppression are affected by a 12-week online yoga program completed by cancer survivors. OUTLINE: Patients receive online yoga intervention once a week (QW) for 12 weeks. After completion of study, patients are followed up at 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Quality-of-Life Assessment | Ancillary studies |
| OTHER | Survey Administration | Ancillary studies |
| OTHER | Yoga | Receive yoga intervention |
Timeline
- Start date
- 2021-11-11
- Primary completion
- 2024-03-22
- Completion
- 2024-06-18
- First posted
- 2021-02-15
- Last updated
- 2025-06-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04754529. Inclusion in this directory is not an endorsement.